CA Patent
CA2782384A1 — Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds
Assigned to Boehringer Ingelheim International GmbH · Expires 2011-06-16 · 15y expired
What this patent protects
Disclosed are processes for preparing compounds of formula I, the compounds are useful as intermediates for preparing indazole and azaindazole substituted compounds.
USPTO Abstract
Disclosed are processes for preparing compounds of formula I, the compounds are useful as intermediates for preparing indazole and azaindazole substituted compounds.
Drugs covered by this patent
- Xiidra (LIFITEGRAST) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.